Plain-English translation of NCT01443728 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Sickle cell disease research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Phase
Testing effectiveness
Sponsor
Gary M Brittenham, MD
Enrollment target
~70 participants
Started
December 2011
Primary completion
June 2013
Age range
3 Years – 20 Years
Last updated on clinicaltrials.gov in August 2024.